Prosight Management, LP Buys Galapagos NV, Albireo Pharma Inc, Accolade Inc, Sells Haemonetics Corp, Prothena Corp PLC, Encompass Health Corp

• New Purchases: ACCD, HUM, STTK, AMED, AGL, ABBV, PANA, WAT, ALEC, LFST, MDXG,
• Added Positions: GLPG, ALBO, IOVA, ZGNX, CNVY, OSCR, XCUR, KALV, ALDX, IRTC, ARNA, MTCR, SIOX, ASMB, CUE, MORF, MGTX, ORGO, ONCR, CLLS,
• Reduced Positions: HAE, PRTA, EHC, ZBH, VRTX, KZR, PRQR, UNH, APTO,
• Sold Out: RCM, QSI, LHCG, AUPH, ATIP, MDT, EVH, CLOV, AKU, NUVB, OPCH, XFOR, RPHM, CANO, ADMA,

For the details of Prosight Management, LP's stock buys and sells, go to https://www.gurufocus.com/guru/prosight+management%2C+lp/current-portfolio/portfolio

1. Prothena Corp PLC (PRTA) - 323,300 shares, 12.67% of the total portfolio. Shares reduced by 23.39%
2. Albireo Pharma Inc (ALBO) - 445,020 shares, 7.64% of the total portfolio. Shares added by 50.81%
3. Galapagos NV (GLPG) - 250,680 shares, 7.26% of the total portfolio. Shares added by 248.17%
4. Cue Biopharma Inc (CUE) - 655,185 shares, 5.25% of the total portfolio. Shares added by 3.94%
5. Arena Pharmaceuticals Inc (ARNA) - 153,400 shares, 5.03% of the total portfolio. Shares added by 11.97%

Prosight Management, LP initiated holding in Accolade Inc. The purchase prices were between $41.3 and $54.56, with an estimated average price of $47.11. The stock is now traded at around $36.380000. The impact to a portfolio due to this purchase was 2.27%. The holding were 97,988 shares as of 2021-09-30.

Prosight Management, LP initiated holding in Humana Inc. The purchase prices were between $389.15 and $471.22, with an estimated average price of $424.73. The stock is now traded at around $445.420000. The impact to a portfolio due to this purchase was 1.93%. The holding were 9,000 shares as of 2021-09-30.

Prosight Management, LP initiated holding in Shattuck Labs Inc. The purchase prices were between $17.57 and $28.95, with an estimated average price of $21.5. The stock is now traded at around $12.480000. The impact to a portfolio due to this purchase was 1.9%. The holding were 169,241 shares as of 2021-09-30.

Prosight Management, LP initiated holding in Amedisys Inc. The purchase prices were between $149.1 and $270.32, with an estimated average price of $208.37. The stock is now traded at around $182.790000. The impact to a portfolio due to this purchase was 1.64%. The holding were 20,000 shares as of 2021-09-30.

Prosight Management, LP initiated holding in Agilon Health Inc. The purchase prices were between $26.15 and $38.72, with an estimated average price of $34.27. The stock is now traded at around $25.510000. The impact to a portfolio due to this purchase was 1.58%. The holding were 109,510 shares as of 2021-09-30.

Prosight Management, LP initiated holding in AbbVie Inc. The purchase prices were between $106.4 and $120.78, with an estimated average price of $114.24. The stock is now traded at around $116.970000. The impact to a portfolio due to this purchase was 1.47%. The holding were 24,800 shares as of 2021-09-30.

Prosight Management, LP added to a holding in Galapagos NV by 248.17%. The purchase prices were between $52.17 and $70.2, with an estimated average price of $59.52. The stock is now traded at around $52.820000. The impact to a portfolio due to this purchase was 5.17%. The holding were 250,680 shares as of 2021-09-30.

Prosight Management, LP added to a holding in Albireo Pharma Inc by 50.81%. The purchase prices were between $27.36 and $35.98, with an estimated average price of $30.98. The stock is now traded at around $28.950000. The impact to a portfolio due to this purchase was 2.57%. The holding were 445,020 shares as of 2021-09-30.

Prosight Management, LP added to a holding in Iovance Biotherapeutics Inc by 97.83%. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $21.070000. The impact to a portfolio due to this purchase was 1.84%. The holding were 274,761 shares as of 2021-09-30.

Prosight Management, LP added to a holding in Zogenix Inc by 60.53%. The purchase prices were between $13.11 and $18.46, with an estimated average price of $15.64. The stock is now traded at around $15.490000. The impact to a portfolio due to this purchase was 1.55%. The holding were 490,882 shares as of 2021-09-30.

Prosight Management, LP added to a holding in Convey Health Solutions Holdings Inc by 79.82%. The purchase prices were between $7.75 and $11.35, with an estimated average price of $8.94. The stock is now traded at around $7.570000. The impact to a portfolio due to this purchase was 1.51%. The holding were 738,012 shares as of 2021-09-30.

Prosight Management, LP added to a holding in Oscar Health Inc by 242.55%. The purchase prices were between $12.25 and $21.25, with an estimated average price of $17.05. The stock is now traded at around $12.180000. The impact to a portfolio due to this purchase was 1.27%. The holding were 188,400 shares as of 2021-09-30.

Prosight Management, LP sold out a holding in R1 RCM Inc. The sale prices were between $18.85 and $22.55, with an estimated average price of $20.69.

Prosight Management, LP sold out a holding in Quantum-Si Inc. The sale prices were between $7.97 and $13.56, with an estimated average price of $9.88.

Prosight Management, LP sold out a holding in LHC Group Inc. The sale prices were between $156.91 and $215.29, with an estimated average price of $187.92.

Prosight Management, LP sold out a holding in Aurinia Pharmaceuticals Inc. The sale prices were between $10.93 and $23.55, with an estimated average price of $15.85.

Prosight Management, LP sold out a holding in ATI Physical Therapy Inc. The sale prices were between $3.39 and $9.42, with an estimated average price of $5.14.

Prosight Management, LP sold out a holding in Medtronic PLC. The sale prices were between $122.75 and $135.17, with an estimated average price of $129.47.